To determine the effect of primary tamoxifen treatment on the vascularity of breast cancers.

被引:0
|
作者
Marson, LP
Kurian, K
Miller, WR
Dixon, JM
机构
[1] Western Gen Hosp, Dept Pathol, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Western Gen Hosp, Edinburgh Breast Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P101
引用
收藏
页码:50 / 50
页数:1
相关论文
共 50 条
  • [21] Determination of p53 protein in tumor extracts of primary breast cancers.
    Lotzniker, M
    Pavesi, F
    Dealessi, F
    Carnevali, L
    Moratti, R
    CLINICAL CHEMISTRY, 1996, 42 (06) : 723 - 723
  • [22] PROLONGED TAMOXIFEN TREATMENT INCREASES SURVIVAL FOR PATIENTS WITH PRIMARY BREAST CANCERS EXPRESSING HIGH LEVELS OF VEGF
    Sanchez, B. Chavez
    Sundqvist, M.
    Stal, O.
    Linderholm, B.
    ANNALS OF ONCOLOGY, 2009, 20 : 47 - 47
  • [23] Endometrial and other primary cancers after tamoxifen treatment of breast cancer - results of retrospective cohort study
    Vrscaj, MU
    Kovacic, J
    Bebar, S
    Djurisic, A
    Fras, PA
    Robic, V
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 95 (01) : 105 - 110
  • [24] MUC1 expression in primary breast cancer: the effect of tamoxifen treatment
    Hanson, JM
    Browell, DA
    Cunliffe, WJ
    Varma, J
    Allen, A
    Hemming, D
    Shenton, BK
    Young, JR
    Higgs, MJ
    Brotherick, I
    Pearson, JP
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 67 (03) : 215 - 222
  • [25] MUC1 expression in primary breast cancer: the effect of tamoxifen treatment
    J.M. Hanson
    D.A. BroweIl
    W.J. Cunliffe
    J. Varma
    A. Allen
    D. Hemming
    B.K. Shenton
    J.R. Young
    M.J. Higgs
    I. Brotherick
    J.P. Pearson
    Breast Cancer Research and Treatment, 2001, 67 : 215 - 222
  • [26] Effect of tamoxifen treatment on MUC-1 expression in primary breast cancer
    Hanson, JM
    Browell, DA
    Cunliffe, WJ
    Young, JR
    Pearson, JP
    Varma, JS
    Allen, A
    Higgs, MJ
    Brotherick, I
    BRITISH JOURNAL OF SURGERY, 1998, 85 (11) : 1576 - 1576
  • [27] Hormone receptor status in primary postmeuopausal breast cancers. Is there an association with hormone replacement therapy?
    Van Gorp, T
    Van Hooff, I
    Mestdagh, C
    De Muylder, X
    Tonglet, R
    Neven, P
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S87 - S88
  • [28] Hormone receptor status in primary postmenopausal breast cancers. Is there an association with hormone replacement therapy?
    Neven, P
    Van Gorp, T
    Van Hooff, I
    Mestdagh, C
    De Muylder, X
    Tonglet, R
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S120 - S121
  • [29] Tamoxifen as the primary treatment in elderly patients with breast cancer
    S. B. Hooper
    A. D. K. Hill
    S. Kennedy
    B. Dijkstra
    L. M. Kelly
    E. W. M. McDermott
    N. O’Higgins
    Irish Journal of Medical Science, 2002, 171 : 28 - 30
  • [30] TREATMENT OF PRIMARY BREAST-CANCER WITH CHEMOTHERAPY AND TAMOXIFEN
    FISHER, B
    REDMOND, C
    BROWN, A
    WOLMARK, N
    WITTLIFF, J
    FISHER, ER
    PLOTKIN, D
    BOWMAN, D
    SACHS, S
    WOLTER, J
    FRELICK, R
    DESSER, R
    LICALZI, N
    GEGGIE, P
    CAMPBELL, T
    ELIAS, EG
    PRAGER, D
    KOONTZ, P
    VOLK, H
    DIMITROV, N
    GARDNER, B
    LERNER, H
    SHIBATA, H
    NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (01): : 1 - 6